SLT is a cost-effective, first-line glaucoma approach

Dr. Nate Radcliffe shares how Lumenis SLT is a cost-effective first-line approach for patients with glaucoma in this video from ASCRS San Diego.

Read Full Article

Nathan M. Radcliffe, MD

Explore Other Resources

Dry EyePress PublicationsTopicTreatment TypeVision Resource Hub
Dry EyePress PublicationsTopicTreatment TypeVision Resource Hub

The 2024 IPL Report

READ MORE

    PB-00038930 Rev A